Lin Xie

机构：Zhejiang Chinese Medical University, Union Hospital, National Institutes for Quantum Science and Technology, National Center for Drug Screening, Affiliated Hangzhou First People's Hospital, Westlake University, School of Medicine, Huazhong University of Science and Technology, Southern Medical University · ORCID：0000-0002-6472-322X

发表论文 199 篇 · 总被引 4107 次 · h-index 32

代表论文

• Resolvin D1 delivery to lesional macrophages using antioxidative black phosphorus nanosheets for atherosclerosis treatment (2024 · Nature Nanotechnology · 被引 167)
• Enhanced radiotheranostic targeting of integrin α5β1 with PEGylation-enabled peptide multidisplay platform (PEGibody): A strategy for prolonged tumor retention with fast blood clearance (2024 · Acta Pharmaceutica Sinica B · 被引 29)
• Design, synthesis and anti-tumor evaluation of novel pyrimidine and quinazoline analogues (2024 · European Journal of Medicinal Chemistry · 被引 17)
• 64Cu-Labeled Stapled Peptide-Based RadiopharmaceuticalsTargeting MDM2/MDMX for Pan-p53 Tumors (2025 · Journal of Medicinal Chemistry · 被引 13)
• Point Defects Enhance Cross‐Plane Thermal Conductivity In Graphite (2025 · Advanced Materials · 被引 11)
• Optimal radiation dose to induce an abscopal effect by combining carbon-ion radiotherapy and anti-CTLA4 antibody (2024 · Neoplasia · 被引 9)